[Yeouido Investment HQ Part 2] DK Tech vs Nanoen Tek vs Kakao Games vs Samsung Electronics, what's the strategy?
Predicted impact: Low
Investment strategy TV segment comparing several stocks; no new company information.
Nanoen Tek나노엔텍
039860 · KOSDAQ · ₩039860 · 나노엔텍
₩4,455▼ ₩215 (4.60%)End-of-day · Oct 30, 2026 · End-of-day prices.
Price · 1Y +42.56%
- Market cap
- ₩170B
- Enterprise value
- ₩121B
- P/E
- 28.9×
- P/B
- 1.8×
- Dividend yield
- 0.0%
- ROE
- 6.2%
- Net margin
- 13.3%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−52.6% from the high
₩3,015Today: ₩4,405 – ₩4,825₩9,390
Returns
- 1W−2.9%
- 1M−1.8%
- 3M+28.0%
- 6M−35.0%
- YTD−25.8%
- 1Y+42.6%
- Volume today
- 544,949
- 0.5× the 20-day average
- Traded today
- ₩2.5B
- Listed shares
- 38,093,053
- EPS (12 months)
- ₩154
- Earnings yield 3.5%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 35 of 100 (50 is a normal day for this stock).
- MomentumFlat-0.7% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Nanoen Tek stock overview
Nanoen Tek (나노엔텍, KRX: 039860) is listed on KOSDAQ, in the Medical & precision devices sector. Nano Entek develops, manufactures and sells in vitro diagnostic medical devices and life science laboratory instruments and consumables, built on its Lab-on-a-Chip platform based on Bio-MEMS technology. Its shares closed at ₩4,455 on Oct 30, 2026, down 4.60% on the day, giving it a market value of ₩170B.
Key facts
- Market cap
- ₩170B
- Sector
- Medical & precision devices
- Latest price change
- −4.60%
- As of
- Oct 30, 2026
- Main business
- Nano Entek develops, manufactures and sells in vitro diagnostic medical devices and life science laboratory instruments and consumables, built on its Lab-on-a-Chip platform based on Bio-MEMS technology.
Quick answers about Nanoen Tek
- What does Nanoen Tek do?
- Nano Entek develops, manufactures and sells in vitro diagnostic medical devices and life science laboratory instruments and consumables, built on its Lab-on-a-Chip platform based on Bio-MEMS technology. Its main products include the FREND System point-of-care immunoassay platform for hormone, thyroid, prostate, cardiac and COVID-19 testing, and cell counters and laboratory automation equipment such as the ADAM and EVE series, serving hospitals, blood centers, pharmaceutical companies and research institutes. S.
- What is the market cap of Nanoen Tek?
- The market capitalisation of Nanoen Tek was ₩170B at the close on Oct 30, 2026.
- Who are the largest shareholders of Nanoen Tek?
- According to the latest official filings, the largest reported holders are A+ Asset (41.26%, as of Mar 20, 2026); Kwak Geun-ho (0.56%, as of Oct 24, 2025); Dimensional Emerging Core Equity Market ETF (0.05%, as of Jul 31, 2026).
- When is the next earnings report from Nanoen Tek?
- Korean companies rarely announce results dates in advance. Based on when Nanoen Tek filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Company profile
Nano Entek develops, manufactures and sells in vitro diagnostic medical devices and life science laboratory instruments and consumables, built on its Lab-on-a-Chip platform based on Bio-MEMS technology. Its main products include the FREND System point-of-care immunoassay platform for hormone, thyroid, prostate, cardiac and COVID-19 testing, and cell counters and laboratory automation equipment such as the ADAM and EVE series, serving hospitals, blood centers, pharmaceutical companies and research institutes. The company sells mainly in the United States, Europe, Japan and Asia through a U.S. subsidiary, local affiliates and distributors; its subsidiary AAI Healthcare provides personalized healthcare services in Korea.
Written by AI from the company's latest annual report.
- Korean name
- 나노엔텍
- Themes
- Medical devices
- CEO
- 정찬일
- Founded
- Nov 1987
- Listed
- Aug 2000
- Listed shares
- 38,093,053
- Fiscal year ends
- Month 12
- Website
- www.nanoentek.com
Similar companies
- TSE131290 · ₩2.5T₩222,000−14.78%
- Kctech281820 · ₩1.7T₩87,500−10.26%
- Classys214150 · ₩1.7T₩26,200−2.24%
- Park Systems140860 · ₩1.5T₩219,500−3.94%
- DI003160 · ₩1.1T₩39,000−10.34%
- LivsMed491000 · ₩995B₩39,400−2.60%
- Seers458870 · ₩859B₩22,400−5.29%
- Curiox Biosystems445680 · ₩851B₩49,400−18.48%
Recent news
Recent filings
See all- Buyback trust contract signedSep 1, 2026
- Half-year report (Jun 2026)Aug 14, 2026
- Results of Extraordinary Shareholders' MeetingMay 29, 2026
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent DirectorsMay 29, 2026
- Quarterly report (Mar 2026)May 15, 2026
Titles in Korean until English translations are added.
Also known as: Nanoen Tek / 나노엔텍 / 039860 / KRX:039860
Source: KRX statistical information